GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>Does anyone realistically expect the HD trial to fail?<

Failure to show non-inferior efficacy is unlikely for the reasons mentioned in #msg-25866013.

However, the trial could conceivably fail because: i) There are serious protocol violations; or ii) Some bizarre side effect shows up in a single patient in the ATryn arm.

All told, success is likely, IMO, but it cannot be taken for granted.